Abstract
Objective The objective was to develop a fully automated algorithm for abdominal fat segmentation and to deploy this method at scale in an academic biobank.
Materials and Methods We built a fully automated image curation and labeling technique using deep learning and distributive computing to identify subcutaneous and visceral abdominal fat compartments from 52,844 CT scans in 13,502 patients in the Penn Medicine Biobank (PMBB). A classification network identified the inferior and superior borders of the abdomen, and a segmentation network differentiated visceral and subcutaneous fat. Following technical evaluation of our method, we conducted studies to validate known relationships with visceral and subcutaneous fat.
Results When compared with 100 manually annotated cases, the classification network was on average within one 5 mm slice for both the superior (0.4±1.1 slices) and inferior (0.4±0.6 slices) borders. The segmentation network also demonstrated excellent performance with interclass correlation coefficients of 1.00 (p<2e-16) for subcutaneous and 1.00 (p<2e-16) for visceral fat on 100 testing cases. We performed integrative analyses of abdominal fat with the phenome extracted from the electronic health record and found highly significant associations with diabetes mellitus, hypertension, renal failure, among other phenotypes.
Conclusion This work presents a fully automated and highly accurate method for the quantification of abdominal fat that can be applied to routine clinical imaging studies to fuel translational scientific discovery.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Sarnoff Cardiovascular Research Foundation (MM), NIH NCATS UL1TR001878, NIH/NHLBI R01 HL137984, R01 AA026302-02, P30 DK0503060 (RC), and the Penn Center for Precision Medicine.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board of the University of Pennsylvania
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Manuscript changes are the following: - shortened to <4000 words. - additional limitations added to discussion - methods/results including retraining using additional high bmi data - compare/contrast multiple deep learning architectures.
Data Availability
Data is available upon reasonable request to the authors.
